RenovoRx (RNXT) Assets (2020 - 2026)
RenovoRx (RNXT) posted Assets of $14.0 million for Q1 2026, up 72.5% sequentially from $8.1 million in Q4 2025, and down 12.8% YoY from $16.0 million in Q1 2025.
RenovoRx (RNXT) Assets (2020 - 2026) Analysis & Trends
RenovoRx has reported Assets for 7 years, with the latest figure at $14.0 million in Q1 2026.
- Quarterly Assets fell 12.8% year-over-year to $14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.0 million (down 12.8% YoY) and the FY2025 annual result came in at $8.1 million, changed 0.28% from the prior year.
- Assets improved to $14.0 million in Q1 2026 per RNXT's latest filing, from $8.1 million in the prior quarter.
- Over five years, Assets peaked at $16.0 million in Q1 2025 and troughed at $1.5 million in Q4 2023.
- A 5-year average of $9.1 million and a median of $9.2 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets sank 79.82% in 2023, then jumped 453.75% in 2024.
- Over 5 years, Assets stood at $7.3 million in 2022, then tumbled by 79.82% to $1.5 million in 2023, then surged by 453.75% to $8.1 million in 2024, then declined by 0.28% to $8.1 million in 2025, then soared by 72.5% to $14.0 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $14.0 million, $8.1 million, and $11.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 19.82 Bn |
| 10 | RenovoRx | 61.96 Mn | 61.96 Mn | 766,000.00 | 11.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.47 Mn |
| Mar 31, 2026 | 13.96 Mn |
| Dec 31, 2025 | 8.10 Mn |
| Sep 30, 2025 | 11.21 Mn |
| Jun 30, 2025 | 13.64 Mn |
| Mar 31, 2025 | 16.01 Mn |
| Dec 31, 2024 | 8.12 Mn |
| Sep 30, 2024 | 10.03 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 4.79 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 6.31 Mn |
| Mar 31, 2023 | 4.56 Mn |
| Dec 31, 2022 | 7.27 Mn |
| Sep 30, 2022 | 9.25 Mn |
| Jun 30, 2022 | 11.24 Mn |
| Mar 31, 2022 | 13.95 Mn |
| Dec 31, 2021 | 16.29 Mn |
| Sep 30, 2021 | 18.18 Mn |